Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A unique restriction endonuclease, BcgI, from Bacillus coagulans

H Kong1, R D Morgan, R E Maunus

  • 1New England Biolabs, Inc., Beverly, MA 01915.

Nucleic Acids Research
|February 25, 1993
PubMed
Summary

Researchers purified and characterized BcgI, a novel restriction enzyme from Bacillus coagulans. This enzyme recognizes a specific DNA sequence and cleaves DNA, releasing the recognition site as a fragment.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Withdrawal notice to "Relationship between coronary microvascular dysfunction (CMD) and left ventricular diastolic function in patients with symptoms of myocardial ischemia with non-obstructive coronary artery disease (INOCA) by cardiovascular magnetic resonance feature-tracking"[ClinRad 79(7) (July 2024) 536-543.

Clinical radiology·2026
Same author

[Identification of advanced heart failure and timing of intervention].

Zhonghua xin xue guan bing za zhi·2025
Same author

[A single-center analysis of pathogenic bacteria distribution and drug resistance in bacterial bloodstream infections among patients with hematological diseases].

Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi·2024
Same author

Relationship between coronary microvascular dysfunction (CMD) and left ventricular diastolic function in patients with symptoms of myocardial ischemia with non-obstructive coronary artery disease (INOCA) by cardiovascular magnetic resonance feature-tracking.

Clinical radiology·2024
Same author

Coronary microvascular dysfunction: prevalence and aetiology in patients with suspected myocardial ischaemia.

Clinical radiology·2024
Same author

[Effects of macrophage glycolytic reprogramming on tuberculosis granuloma formation].

Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases·2023

Area of Science:

  • Molecular Biology
  • Enzymology
  • Genetics

Background:

  • Restriction enzymes are crucial tools in molecular biology for DNA manipulation.
  • Existing restriction enzymes are classified into three main types based on their cleavage mechanisms.
  • Novel restriction enzymes with unique properties are continuously sought for advanced applications.

Purpose of the Study:

  • To purify and characterize a newly discovered restriction enzyme, designated BcgI.
  • To elucidate the DNA recognition sequence and cleavage mechanism of BcgI.
  • To investigate the cofactor requirements and kinetic properties of BcgI.

Main Methods:

  • Purification of BcgI from Bacillus coagulans.
  • DNA cleavage assays to determine recognition sequence and cleavage sites.

Related Experiment Videos

  • Enzyme kinetics studies using Mg++ and S-adenosylmethionine (AdoMet) or sinefungin.

    • Main Results:

    • BcgI recognizes the DNA sequence CGAN6TGC.
    • BcgI cleaves both DNA strands, releasing the recognition sequence as a 34-bp fragment with 2-base 3'-extensions.
    • Cleavage requires Mg++ and AdoMet; sinefungin can substitute for AdoMet, indicating unique cofactor interactions.

    Conclusions:

    • BcgI represents a novel class of restriction enzyme due to its unique cleavage pattern.
    • The enzyme's properties offer new possibilities for DNA engineering and analysis.
    • Understanding BcgI's mechanism provides insights into DNA-modifying enzyme diversity.